1. ALLA AKTIER
  2. NYHETER
  3. Q-LINEA

Q-Linea

Nyheter Q-Linea Nyheter alla bolag

Q-linea strengthens its presence in Finland and the Baltics through partnership with Labema Oy

Q-linea AB (Publ) (OMX: QLINEA) today announces that the company has entered into an agreement with Labema Oy for ASTar® Instrument and consumables in Finland and the Baltic States.

“The Nordics is our home market, and it is important for us to be well represented across the region. Labema is a knowledgeable, highly regarded distributor with a strong presence within clinical microbiology,” said Thomas Fritz, CCO at Q-linea.

“We look forward to an exciting future and partnership. Such high-quality, innovative products as ASTar enable an expansion of our business to clinical microbiology laboratories in hospitals,” said Mohammed Benlakhdar, CEO at Labema.

With the appointment of Labema Oy, Q-linea continues to grow its European sales network. Q-linea already has representation, direct or through partners, in the following countries: France, Italy, Norway, Poland, Sweden, and the UK.

Established in 1988, Labema provides 35 years of experience and expertise within microbiology, molecular biology and laboratory automation. The company offers diagnostic equipment and consumables to public healthcare, research laboratories and the food industry.

Learn more about Labema: https://www.labema.fi/en/

For more information, please contact:

Jonas Jarvius, CEO, Q-linea AB
Jonas.Jarvius@qlinea.com
+46 (0) 70-323 77 60

Christer Samuelsson, CFO /IR, Q-linea AB
Christer.Samuelsson@qlinea.com
+46 (0) 70-600 15 20

About Q-linea

Q-linea is an innovative infection diagnostics company that primarily develops instruments and disposables for rapid and reliable infection diagnostics. Our vision is to help save lives by ensuring antibiotics continue to be an effective treatment for future generations. Q-linea develops and delivers preferred solutions for healthcare providers, enabling them to accurately diagnose and treat infectious disease in the shortest possible time. The company's lead product ASTar® is a fully automated instrument for antibiotic susceptibility testing (AST), giving a susceptibility profile within six hours directly from a positive blood culture. For more information, please visit www.qlinea.com.

Attachments

Q-linea strengthens its presence in Finland and the Baltics through partnership with Labema Oy

Datum 2023-10-19, kl 08:50
Källa MFN
Bifogade filer
Q-linea strengthens its presence in Finland and the Baltics through partnership with Labema Oy
Affiliate
Skapa konto direkt med BankID hos Skilling så får du tillgång till tusentals finansmarknader inom valuta, aktier, krypto och mycket mer. Välj bland 1200+ CFD-instrument över 7 tillgångsklasser till konkurrenskraftiga priser. Skilling erbjuder också en kapitalförsäkring.
CFD är komplexa instrument och har en hög risk att förlora pengar snabbt på grund av hävstång. 77% av icke-professionella kunder förlorar pengar när de handlar med CFD med denna leverantör.